CoChat

Cognitive and Behavioral Therapies Alone versus in Combination with Fluvoxamine in the Treatment of Obsessive Compulsive Disorder

VAN BALKOM, ANTON J. L. M., DE HAAN, ELSE, VAN OPPEN, PATRICIA, SPINHOVEN, PHILIP, HOOGDUIN, KEES A. L., VAN DYCK, RICHARD · 1998 · The Journal of Nervous & Mental Disease

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The purpose of this treatment package design study was to investigate the differential efficacy of cognitive therapy or exposure in vivo with response prevention for obsessive compulsive disorder (OCD) versus the sequential combination with fluvoxamine. Patients with OCD (N = 117) were randomized to one of the following five conditions: a) cognitive therapy for weeks 1 to 16, b) exposure in vivo with response prevention for weeks 1 to 16, c) fluvoxamine for weeks 1 to 16 plus cognitive therapy in weeks 9 to 16, d) fluvoxamine for weeks 1 to 16 plus exposure in vivo with response prevention in weeks 9 to 16, or e) waiting list control condition for weeks 1 to 8 only. Assessments took place before treatment (pretest) and after 8 (midtest), and 16 weeks (posttest). In the first 8 weeks, six treatment sessions were delivered. During weeks 9 to 16, another 10 sessions were given. Thirty-one patients dropped out. Outcome was assessed by patient-, therapist- and assessor-ratings of the Anxiety Discomfort Scale, the Yale-Brown Obsessive Compulsive Scale, and the Padua Inventory-Revised. In contrast with the four treatments, after 8 weeks the waiting list control condition did not result in a significant decrease of symptoms. After 16 weeks of treatment, all four treatment packages were effective on these OCD ratings, but they did not differ among each other in effectiveness. In OCD, the sequential combination of fluvoxamine with cognitive therapy or exposure in vivo with response prevention is not superior to either cognitive therapy or exposure in vivo alone.

Overview

Integrity signals

Registry

Crossref · 10.1097/00005053-199808000-00007

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 1

  1. Fawcett, 1987, Psychopharmacol Bull, 23, 322

Cited by

See all 250

Metadata

Authors
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R.
Affiliations
  • Leiden University (NL)
  • Radboud University Nijmegen (NL)
Venue
The Journal of Nervous & Mental Disease
Published
1998-08
Volume
186
Issue
8
Pages
492-499
ISSN
0022-3018 (ISSN-L)
OpenAlex
W2045416177
Cited by
250
References
16
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 1 · 2020: 1 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 9 · 2013: 8 · 2012: 45
FWCI
5.47
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Nervous and Mental Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
obsessive-compulsive disorder, fluvoxamine, cognitive therapy, exposure and response prevention, in vivo exposure, combination therapy, sequential therapy, treatment efficacy, antidepressant augmentation
MeSH terms
Adult, Combined Modality Therapy, Desensitization, Psychologic, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Patient Dropouts, Personality Inventory, Psychiatric Status Rating Scales, Severity of Illness Index, Cognitive Behavioral Therapy, Fluvoxamine, Treatment Outcome, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cognitive and Behavioral Therapies Alone versus in Combination with Fluvoxamine in the Treatment of Obsessive Compulsive Disorder. https://app.cochat.ai/papers/10.1097/00005053-199808000-00007
The paper
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998). Cognitive and Behavioral Therapies Alone versus in Combination with Fluvoxamine in the Treatment of Obsessive Compulsive Disorder. The Journal of Nervous & Mental Disease. https://doi.org/10.1097/00005053-199808000-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.